Ankündigung • Nov 05
Vikas WSP Limited to Report Q2, 2026 Results on Nov 10, 2025 Vikas WSP Limited announced that they will report Q2, 2026 results on Nov 10, 2025 Ankündigung • Aug 06
Vikas WSP Limited, Annual General Meeting, Aug 30, 2025 Vikas WSP Limited, Annual General Meeting, Aug 30, 2025, at 12:00 Indian Standard Time. Ankündigung • Jul 30
Vikas WSP Limited to Report Q1, 2026 Results on Aug 05, 2025 Vikas WSP Limited announced that they will report Q1, 2026 results on Aug 05, 2025 Ankündigung • May 20
Vikas WSP Limited to Report Q4, 2025 Results on May 28, 2025 Vikas WSP Limited announced that they will report Q4, 2025 results on May 28, 2025 Ankündigung • Feb 04
Vikas WSP Limited to Report Q3, 2025 Results on Feb 12, 2025 Vikas WSP Limited announced that they will report Q3, 2025 results on Feb 12, 2025 Ankündigung • Jan 01
Vikas WSP Limited Announces Board Changes Vikas WSP Limited announced Second Meeting of Committee of Creditors (CoC) held on 02 nd December 2024, approved and accept the unsigned Resignation submitted by Mr. Gunjan Kumar Karn, the Company Secretary-Cum-Compliance Officer and KMP of the CD through email dated 29.11.2024. Ankündigung • Aug 28
Vikas WSP Limited, Annual General Meeting, Sep 20, 2024 Vikas WSP Limited, Annual General Meeting, Sep 20, 2024, at 11:00 Indian Standard Time. Ankündigung • Aug 20
Vikas WSP Limited to Report Q1, 2025 Results on Aug 27, 2024 Vikas WSP Limited announced that they will report Q1, 2025 results on Aug 27, 2024 Ankündigung • Oct 14
Vikas WSP Limited to Report Q2, 2024 Results on Oct 30, 2023 Vikas WSP Limited announced that they will report Q2, 2024 results on Oct 30, 2023 Ankündigung • Sep 14
Vikas WSP Limited to Report Q1, 2024 Results on Sep 19, 2023 Vikas WSP Limited announced that they will report Q1, 2024 results on Sep 19, 2023 Ankündigung • Jun 27
Vikas WSP Limited, Annual General Meeting, Jul 28, 2023 Vikas WSP Limited, Annual General Meeting, Jul 28, 2023, at 11:00 Indian Standard Time. Agenda: To Receive, consider and adopt the audited Standalone Financial Statements of the Company for the Financial Year Ended 31st March, 2022, including Audited Balance Sheet as at March 31, 2022, the Statement of Profit & Loss and the Cash Flow Statement for the year ended on that date together with reports of the auditors' and the report to the shareholders thereon; to consider the appointment of Mr. Pawan Singla, who retires by rotation as a director; to consider the appointment of Mr. Buta Singh as a director of the company; to consider the appointment of Mr. Baljinder Singh as a director of the company; and to consider other matters. Reported Earnings • Jan 04
Full year 2022 earnings released: ₹7.98 loss per share (vs ₹5.60 loss in FY 2021) Full year 2022 results: ₹7.98 loss per share (further deteriorated from ₹5.60 loss in FY 2021). Net loss: ₹1.64b (loss widened 43% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Additional Non-Executive Independent Woman Director Suman Devi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Jun 13
Third quarter 2022 earnings released: ₹0.41 loss per share (vs ₹0.47 loss in 3Q 2021) Third quarter 2022 results: ₹0.41 loss per share (up from ₹0.47 loss in 3Q 2021). Net loss: ₹84.2m (loss narrowed 11% from 3Q 2021). Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 3 independent directors. 4 non-independent directors. Additional Non-Executive Independent Woman Director Suman Devi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Board Change • Dec 15
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Executive Director Kamini Jindal is the most experienced director on the board, commencing their role in 2012. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 04
First quarter 2022 earnings released: ₹0.63 loss per share (vs ₹0.13 profit in 1Q 2021) The company reported a poor first quarter result with weaker earnings, revenues and control over costs. First quarter 2022 results: Revenue: ₹4.74m (down 100% from 1Q 2021). Net loss: ₹128.3m (down ₹154.0m from profit in 1Q 2021). Valuation Update With 7 Day Price Move • Aug 19
Investor sentiment improved over the past week After last week's 20% share price gain to ₹5.75, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 18x in the Chemicals industry in India. Total loss to shareholders of 15% over the past year. Valuation Update With 7 Day Price Move • Jun 19
Investor sentiment improved over the past week After last week's 17% share price gain to ₹7.00, the stock trades at a trailing P/E ratio of 24.6x. Average trailing P/E is 22x in the Chemicals industry in India. Negligible returns to shareholders over past year. Valuation Update With 7 Day Price Move • Jun 05
Investor sentiment improved over the past week After last week's 16% share price gain to ₹6.15, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 3.9% over the past year. Reported Earnings • May 06
Third quarter 2021 earnings released: ₹0.47 loss per share (vs ₹0.30 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: ₹2.82m (down 100% from 3Q 2020). Net loss: ₹94.3m (down 255% from profit in 3Q 2020). Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment improved over the past week After last week's 22% share price gain to ₹7.05, the stock trades at a trailing P/E ratio of 12.3x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 42% over the past year. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment improved over the past week After last week's 21% share price gain to ₹6.15, the stock is trading at a trailing P/E ratio of 10.4x, up from the previous P/E ratio of 8.7x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past year is a loss of 8.2%. Is New 90 Day High Low • Mar 02
New 90-day high: ₹5.65 The company is up 18% from its price of ₹4.80 on 02 December 2020. The Indian market is up 16% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improved over the past week After last week's 19% share price gain to ₹4.60, the stock is trading at a trailing P/E ratio of 7.6x, up from the previous P/E ratio of 6.3x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past year is a loss of 39%. Reported Earnings • Jan 23
Second quarter 2021 earnings released: EPS ₹0.003 The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹730.5m (down 63% from 2Q 2020). Net income: ₹608.0k (down 99% from 2Q 2020). Profit margin: 0.1% (down from 3.0% in 2Q 2020). The decrease in margin was driven by lower revenue. Valuation Update With 7 Day Price Move • Dec 03
Market bids up stock over the past week After last week's 27% share price gain to ₹5.25, the stock is trading at a trailing P/E ratio of 5.5x, up from the previous P/E ratio of 4.3x. This compares to an average P/E of 17x in the Chemicals industry in India. Total return to shareholders over the past year is a loss of 43%. Is New 90 Day High Low • Nov 12
New 90-day low: ₹3.70 The company is down 45% from its price of ₹6.75 on 14 August 2020. The Indian market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period. Is New 90 Day High Low • Oct 20
New 90-day low: ₹3.80 The company is down 38% from its price of ₹6.15 on 22 July 2020. The Indian market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Is New 90 Day High Low • Sep 21
New 90-day low: ₹4.90 The company is down 31% from its price of ₹7.10 on 23 June 2020. The Indian market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period. 